Ad-hoc | 9 September 2002 08:30

Rhein Biotech N.V. english

Transfer to the Frankfurt Geregelter Markt confirmed for 23rd September Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– Transfer to the Frankfurt Geregelter Markt confirmed for 23rd September Following their announcement on 4th September, Rhein Biotech announced today that the Deutsche Börse has confirmed the transfer of its listing from the Neuer Markt to the Geregelter Markt. The last day of trading at the Neuer Markt will be 20th September and the new listing on the Geregelter Markt will commence on 23rd September. As previously communicated, the reason for the change in segment is the takeover of Rhein Biotech by Berna Biotech AG on August 1, 2002. Rhein Biotech will furthermore evaluate the modalities and consequences of a future de-listing from the Frankfurt stock exchange. end of ad-hoc-announcement (c)DGAP 09.09.2002 Issuer’s information/explanatory remarks concerning this ad-hoc-announcement: Berna Biotech AG (Swiss Exchange: BBIN) has acquired 92.2 percent of the Rhein Biotech share capital by means of a friendly takeover. Rhein Biotech is now a full member of the Berna Biotech Group. The integration of the two companies will create a leading player for innovation in vaccines. An update on the progress of the integration will be provided by Berna Biotech in September. For further information: Company Contact: Marcel Jacobs Communication Manager Rhein Biotech NV T: +31 (0)43 / 35 67 894 F: +31 (0)43 / 35 67 899 E: m.jacobs@rheinbiotech.com Media Contact Carsten Heinrichs, IR-Consultant vom Hoff Kommunikation GmbH, T: +49 (0)211 / 515 805 12 F: +49 (0)211 / 515 805 55 E: c.heinrichs@vomhoff.de ——————————————————————————– WKN: 919544; ISIN: NL0000230324; Index: NEMAX 50 Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen, Düsseldorf, Hamburg, München, Stuttgart, Hannover 090830 Sep 02